Home > Financial Ratios > WINDLAS BIOTECH

WINDLAS BIOTECH
EV/Core EBITDA

    Back to All Ratios
COMMUNITY POLL
for WINDLAS BIOTECH
Please provide your vote to see the results

WINDLAS BIOTECH Last 5 Year EV/Core EBITDA History

[Consolidated]

Mar2025Mar2024Mar2023Mar2022Mar2021
   EV/Core EBITDA(x) 19.5611.296.365.920.11

What is the latest EV/Core EBITDA ratio of WINDLAS BIOTECH ?

The latest EV/Core EBITDA ratio of WINDLAS BIOTECH is 19.56 based on Mar2025 Consolidated results.
Year EV/Core EBITDA
Mar202519.56
Mar202411.29
Mar20236.36
Mar20225.92
Mar20210.11

How is EV/Core EBITDA of WINDLAS BIOTECH Trending?

Years EV/Core EBITDA % Change
Mar2025 19.56
73.25
Mar2024 11.29
77.52
Mar2023 6.36
7.43
Mar2022 5.92
5,281.82
Mar2021 0.11 -

Other Financial Ratios of WINDLAS BIOTECH


Compare EV/Core EBITDA ratio of peers of WINDLAS BIOTECH

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
WINDLAS BIOTECH ₹1,568.6 Cr -0.4% -9.6% -4.2% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹431,628.0 Cr -0.1% 4.7% 6.2% Stock Analytics
DIVIS LABORATORIES ₹167,975.0 Cr -1.7% 2.5% 12.3% Stock Analytics
TORRENT PHARMACEUTICALS ₹145,804.0 Cr -1.1% 7.6% 45.4% Stock Analytics
DR REDDYS LABORATORIES ₹108,829.0 Cr -0.4% 6.3% 14.7% Stock Analytics
CIPLA ₹106,768.0 Cr -2.3% 0.3% -8.9% Stock Analytics


WINDLAS BIOTECH Share Price vs Sensex


Share Price Returns(%) 1 Week 1 Month 1 Year
WINDLAS BIOTECH

-0.4%

-9.6%

-4.2%

SENSEX

-4.1%

-5.8%

5.8%


You may also like the below Video Courses